CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahue-Giangreco, M.
Right arrow Articles by Bernstein, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahue-Giangreco, M.
Right arrow Articles by Bernstein, L.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 209-214, March 2003
© 2003 American Association for Cancer Research

Induced Abortion, Miscarriage, and Breast Cancer Risk of Young Women1

Maya Mahue-Giangreco, Giske Ursin, Jane Sullivan-Halley and Leslie Bernstein2

Department of Preventive Medicine and Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California 90033

Early studies of breast cancer raised substantial concern regarding risk associated with induced abortion and miscarriage. Literature reviews suggest that study findings depend heavily on the comparison group and that the use of parous women as a reference group for nulliparous women may artificially inflate risk. To examine the individual effects of induced abortion and miscarriage on breast cancer risk of parous and nulliparous women, 744 patients <=40 years of age and diagnosed from 1983–1988 were matched by parity, age, and race with controls living in the same neighborhood in Los Angeles County. In-person interviews were conducted to obtain a detailed reproductive history. Risk estimates were obtained by conditional logistic regression using nulligravid women as the reference group for nulliparous women with a history of incomplete pregnancy and parous women with no incomplete pregnancies as the reference group for parous women with a history of incomplete pregnancy. Breast cancer risk of parous women was unrelated to a history of miscarriage or induced abortion. Breast cancer risk was reduced among nulliparous women with a history of induced abortion relative to nulligravid women, although the risk estimate was imprecise. Risk declined as the number of induced abortions increased (P = 0.04). Our results do not support the hypothesis that induced abortion or miscarriage increase the breast cancer risk of young women.




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
G. L. Gierach, F. Modugno, and R. B. Ness
Relations of Gestational Length and Timing and Type of Incomplete Pregnancy to Ovarian Cancer Risk
Am. J. Epidemiol., March 1, 2005; 161(5): 452 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.